Mochida Pharmaceutical is a smaller listed Japanese pharma company. This is the first time Mochida has explored project opportunities in Australia. "Mochida has implemented “MOIRe”, an open innovation program for drug discovery based on proposals from academic researchers since 2019 in Japan. From this year, Mochida welcomes applications from overseas researchers with a great interest in connecting drug discovery seeds to pharmaceutical development for collaborative research."
Interest areas:
Obstetrics and Gynaecology – Endometriosis, Pre-eclampsia – drug candidates/drug target candidates
Funding: Maximum U$50,000 (~A$ 70,000) per project
Application period: 1 July to 30 September 2020
Application website: http://www.mochida.co.jp/english/business/rd_openinnovation_ej.html
Whilst applications can be made directly to Mochida we request interested researchers to run draft applications past either Andrew Bray (BD, FMNHS) and/or Julian Vultaggio (Monash Innovation), to check for fit, confidentiality issues (the application is NON-confidential) and to identify any IP issues, by mid September. We will prefer to make a Monash submission by the deadline and in consultation with the company.
No comments:
Post a Comment